Rankings
▼
Calendar
ELUT FY 2021 Earnings — Elutia Inc. Revenue & Financial Results | Market Cap Arena
ELUT
Elutia Inc.
$47M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$47M
+11.0% YoY
Gross Profit
$19M
40.1% margin
Operating Income
-$23M
-48.6% margin
Net Income
-$25M
-52.4% margin
EPS (Diluted)
$-2.38
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$16M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$67M
Total Liabilities
$54M
Stockholders' Equity
$14M
Cash & Equivalents
$30M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$47M
$43M
+11.0%
Gross Profit
$19M
$21M
-7.5%
Operating Income
-$23M
-$14M
-69.4%
Net Income
-$25M
-$22M
-13.8%
← FY 2020
All Quarters
Q3 2021 →